Fukuda DenshiFUKUDA DENSHI CO.,LTD.6960東証スタンダード電気機器FY ending Mar 2026, consolidated, J-GAAP

Fukuda Denshi FY ending Mar 2020 results

About 38% of Fukuda Denshi's sales come from medical treatment equipment, with physiological diagnostic equipment and consumables and other products making up much of the rest.

Out of every ¥100 of sales, about ¥10 is left as operating profit.

Where the money goes

Where ¥100 of sales goes

For every ¥100 Fukuda Denshi sells, how much goes where, and how much is kept.

FY ending Mar 2020

Cost of sales: ¥59
SG&A: ¥31
Operating profit: ¥10
Net profit kept: ¥7

Margin funnel (derived from reported values)Gross margin 40.6% → Operating margin 10.0% → Net margin 7.2%

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2020

medical treatment equipment¥50.6B
38%
Op. margin 13.7%Industry: Medical Devices
physiological diagnostic equipment¥38.2B
29%
Op. margin 6.6%Industry: Medical Devices
consumables and other products¥34.3B
26%
Op. margin 8.8%Industry: Medical Devices
patient monitoring equipment¥10.2B
8%
Op. margin 7.8%Industry: Medical Devices

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第77期(2023/04/01－2024/03/31)
ID S100TU7S2024-06-27Open
EDINET (FSA Japan)
有価証券報告書－第75期(令和3年4月1日－令和4年3月31日)
ID S100OJ3B2022-06-29Open
EDINET (FSA Japan)
有価証券報告書－第74期(令和2年4月1日－令和3年3月31日)
ID S100LSU02021-06-29Open

Extracted from XBRL: 45 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open Markdown Share on X Save image